Author

Yi-Wan Guo

h-index 3 View on Semantic Scholar

We have 1 of 13 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Dual Targeting Engineered Binding Proteins Block SARS-CoV-2 Infection and Complement Activation.

SBP10 and SBP16 function as dual targeting engineered binding proteins that inhibit viral entry while attenuating complement-mediated inflammation, highlighting a promising therapeutic strategy for controlling SARS-CoV-2 infection and its associated immune dysregulation.

Fan Pu, Yiwan Guo, Xinni Pan et al. · Antiviral Research · 0 citations